Company profile
Forza Innovations Inc.
OTC: FORZ · Healthcare · Medical - Devices
#1037 of 1,418 Healthcare companies by revenuetop-decile growth
EA Score
——FH —DQ 19GM —SS 20
v0.1 · 25/100 weight · pillars only
↑ revenue growth (YoY), Piotroski F · ↓ return on assets, workforce scale
Methodology →Revenue TTM
$94.0k
Rev growth YoY (TTM)
+8.7%
Net income (FY)
-$4.8M
Employees
2
as of 2026-08-27
Market cap
$252.2k
as of 2026-08-27
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$114.6k$114.6k2023
Net income-$4.8M-$4.8M2023
Operating income-$926.7k-$926.7k2023
Total assets$91.4k$91.4k2023
Liabilities$4.7M$4.7M2023
Equity-$4.6M-$4.6M2023
Revenue trend
FY2017 – FY2023 · USD
FY17
FY17
FY18
FY20
FY22
FY22
FY23
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Forza Innovations Inc.’s revenue?
Forza Innovations Inc. booked $114.6k in FY2023 revenue, growing 343% year over year — faster than 92% of Healthcare companies we track, at a -4150.0% net margin.
Peers · Healthcare
Microbot Medical Inc.54DBullfrog AI Holdings, Inc. Common Stock30DCreative Edge Nutrition, Inc.——Biostax Corp.——BioMark Diagnostics Inc.——Finch Therapeutics Group, Inc.——Neighbors
San Diego →Key facts
CEOEvan Schick
SectorHealthcare
IndustryMedical - Devices
HeadquartersSan Diego, CA
ExchangeOTC: FORZ
Employees2
IPO date2019-10-17
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.